MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0196926
Wayonext Pharmaceuticals Private Limited
Wayonext Pharmaceuticals Private Limited - pharma in Kalyan, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹17.13 Cr
▲ 74% YoY
Net profit · FY 2025
₹31.18 Lakh
Net margin 1.8%
EBITDA · FY 2025
₹68.55 Lakh
EBITDA margin 4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.6 Lakh
Issued & subscribed
Open charges
₹7.76 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Wayonext Pharmaceuticals Private Limited
Data last updated:
Wayonext Pharmaceuticals Private Limited is a private limited company based in Kalyan, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73200MH2018PTC309562. Its GSTIN is 27AACCW2102J1ZK (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.6 Lakh. It is led by directors Sandeep Balu Chikhalkar and Shashikant Satyadev Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kalyan, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.13 Cr, a growth of 74% compared to the previous year. For the same year it recorded a net profit of ₹31.18 Lakh (net margin 1.8%) and EBITDA of ₹68.55 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years and 61% over five years.
As per MCA filings, the company has open charges of ₹7.76 Cr on record.
Wayonext Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0196926). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U73200MH2018PTC309562
Registration Number 309562
Incorporation Date 17 May 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0196926
Recognitions & Rankings of Wayonext Pharmaceuticals
Contact details
Wayonext Pharmaceuticals Private Limited's registered office is in Kalyan, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit No. 2 Lower Ground Floor, Gnp Galaxy Phase Ambarnath, Kalyan, Maharashtra, India – 421501
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Wayonext Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Wayonext Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Wayonext Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Wayonext Pharmaceuticals Private Limited, buy the company report.
Financials of Wayonext Pharmaceuticals Private Limited
FY 2025 filings availableWayonext Pharmaceuticals Private Limited reported revenue of ₹17.13 Cr (up 74% YoY) for FY 2025.
Revenue · FY 2025
₹17.13 Cr ▲ 74%
Net profit · FY 2025
₹31.18 Lakh margin 1.8%
EBITDA · FY 2025
₹68.55 Lakh margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 74%
3 years · compounded
▲ 67%
5 years · compounded
▲ 61%
EBITDA CAGR growth
1 year
▲ 69%
3 years · compounded
▲ 86%
5 years · compounded
▲ 102%
Revenue has grown at a compounded annual rate (CAGR) of 61% over five years, including 74% growth in the latest year. EBITDA rose 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹68.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wayonext Pharmaceuticals Private Limited, buy the company report.
Board of directors of Wayonext Pharmaceuticals Private Limited
Wayonext Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Balu Chikhalkar | Director | 17 May 2018 | 8 Years 5 Months | Current |
| Shashikant Satyadev Singh | Director | 17 May 2018 | 8 Years 5 Months | Current |
Peer comparison
Wayonext Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Matish Healthcare Private Limited | ₹17.22 Cr (FY 2024) | -10.0% | Vadodara, Gujarat, India | |||
| Rangodadhi Chemicals Private Limited | ₹17.2 Cr (FY 2025) | -18.0% | Ahmedabad, Gujarat, India | |||
| Wayonext Pharmaceuticals Private Limitedthis company | ₹17.13 Cr (FY 2025) | ₹31.18 Lakh | 1.8% | 74.0% | Kalyan, Maharashtra, India | |
| Vamsi Pharma Private Limited | ₹17.11 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Wayonext Pharmaceuticals Private Limited, buy the company report.
Auditor
Wayonext Pharmaceuticals Private Limited is audited by Nitin Mane & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Nitin Mane & Associates | FY 2024 | 143088W |
Shareholding
The shareholding of Wayonext Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Wayonext Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.76 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jul 2026 | 101356596 | Others | ₹64.4 Lakh | Open | |
| 26 May 2025 | 101131830 | Others | ₹19.2 Lakh | Open | |
| 20 May 2025 | 101127707 | Others | ₹5 Cr | Open | |
| 28 Mar 2025 | 101092539 | Others | ₹1.23 Cr | Open | |
| 23 Sep 2024 | 101008207 | Others | ₹70 Lakh | Open |
To see the full charge records of Wayonext Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Wayonext Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wayonext Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wayonext Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCW2102J1ZK | Maharashtra | Active | 03 Aug 2018 |
To see the full GST registrations and return filing status of Wayonext Pharmaceuticals Private Limited, buy the company report.
Recent activity
Wayonext Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Sachin Ganesh Ghadekar ceased to be Director on 16 Aug 2019.
Charges
A charge with Others amounted to Rs. 64.40 Lakh with Charge ID 101356596 was registered on 08 Jul 2026.
Charges
A charge with Others of Rs. 500.00 Lakh registered on 20 May 2025 with Charge ID 101127707 was modified on 27 Feb 2026.
AGM
Wayonext Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 19.20 Lakh with Charge ID 101131830 was registered on 26 May 2025.
Charges
A charge with Others amounted to Rs. 500.00 Lakh with Charge ID 101127707 was registered on 20 May 2025.
Filing
Wayonext Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 122.58 Lakh with Charge ID 101092539 was registered on 28 Mar 2025.
Charges
A charge with Others amounted to Rs. 70.00 Lakh with Charge ID 101008207 was registered on 23 Sep 2024.
Ceased
Sachin Ganesh Ghadekar ceased to be Director.
Ceased
Sumanlata Kuwar Singh ceased to be Director.
Appointed
Sandeep Balu Chikhalkar was appointed as Director.
Appointed
Shashikant Satyadev Singh was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Wayonext Pharmaceuticals is an active private limited company based in Kalyan, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 May 2018 (8+ years old) and is registered under CIN U73200MH2018PTC309562.
Wayonext Pharmaceuticals has 2 current directors:
- Sandeep Balu Chikhalkar - Director
- Shashikant Satyadev Singh - Director
The latest financial statements of Wayonext Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Wayonext Pharmaceuticals is 27AACCW2102J1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Wayonext Pharmaceuticals is U73200MH2018PTC309562. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wayonext Pharmaceuticals was incorporated on 17 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Wayonext Pharmaceuticals by revenue are Matish Healthcare Private Limited, Rangodadhi Chemicals Private Limited, Vamsi Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sachin Ganesh Ghadekar ceased to be Director on 16 Aug 2019. Sumanlata Kuwar Singh ceased to be Director on 16 Aug 2019. Sandeep Balu Chikhalkar was appointed as Director on 17 May 2018. Wayonext Pharmaceuticals has 4 board changes on record in total.
Yes, Wayonext Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0196926).
The registered office of Wayonext Pharmaceuticals is at Unit No. 2 Lower Ground Floor, Gnp Galaxy Phase Ambarnath, Kalyan, Maharashtra, India – 421501.
Wayonext Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages